KLK3 and prostate carcinoma: Although the findings from the CAP study do not support using the PSA test as an approach for population-based screening, combining PSA measurements with other approaches that either identify individuals for additional testing or strengthen the capacity to diagnose prostate cancer have significant merit, and it is based on this concept that the current study has been performed.